Induced pluripotent stem cell derived cardiomyocytes (iPSC-CM) have the 30 potential to transform regenerative cardiac medicine and the modelling of cardiac 31 disease. This is of particular importance in the context of diabetic cardiomyopathy 32 where diabetic individuals exhibit reduced cardiac diastolic contractile performance in 33 the absence of vascular disease, significantly contributing towards high cardiovascular 34 morbidity. In this study, the capacity of iPSC-CM to act as a novel cellular model of 35 cardiomyocytes was assessed. The diabetic phenotype is characterised by insulin 36 resistance, therefore there was a specific focus upon metabolic parameters. Despite 37 expressing crucial insulin signalling intermediates and relevant trafficking proteins, it 38 was identified that iPSC-CM do not exhibit insulin-stimulated glucose uptake. iPSC-39 CM are spontaneously contractile however contraction mediated uptake was not found 40 to mask any insulin response. The fundamental limitation identified in these cells was 41 a critical lack of expression of the insulin sensitive glucose transporter GLUT4. Using 42 comparative immunoblot analysis and the GLUT-selective inhibitor BAY-876 to 43 quantify expression of these transporters, we show that iPSC-CM express high levels 44 of GLUT1 and low levels of GLUT4 compared to primary cardiomyocytes and cultured 45 adipocytes. Interventions to overcome this limitation were unsuccessful. We suggest 46 that the utility of iPSC-CMs to study cardiac metabolic disorders may be limited by 47 their apparent foetal-like phenotype. 48
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273 Contraction is a key regulator of glucose uptake in iPSC-CM 274 In addition to insulin, contraction is a potent stimulus to initiate GLUT4 275 translocation to the plasma membrane and therefore also increase cellular glucose 276 uptake [28] . Whilst insulin-stimulated glucose uptake can be recorded in contracting 277 myocardium, this response is considerably less powerful than that recorded from 278 quiescent isolated cardiomyocytes [29, 30] . It was considered possible that the 279 spontaneous contractile activity of iPSC-CM could potentially be masking a small yet 280 significant insulin response. In order to assess this possibility basal and insulin 281 stimulated glucose uptake were recorded in iPSC-CM in the presence and absence of 282 blebbistatin. Inhibition of contraction via this method resulted in a significant reduction 283 in iPSC-CM glucose uptake by >50%, in the presence or absence of insulin (Fig. 3) . 284 However, regardless of whether cells were contracting or not, insulin failed to 285 significantly increase glucose uptake. This suggests that whilst contraction is 286 undoubtedly a critical regulator of metabolic demand and therefore substrate uptake 287 in iPSC-CM, it does not interfere with any metabolic regulation of these cells by insulin. 
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Whilst there are numerous proteins and interactions responsible for the 299 regulated trafficking of GLUT4, ultimately one of the foundational requirements to 300 facilitate this process is sufficient expression of GLUT4 itself. In vivo, cardiac GLUT1 301 expression predominates during early development prior to a metabolic switch and 302 rapid induction of GLUT4 protein during early post-natal life with a corresponding 303 repression of GLUT1 [31] . Given the generally reported classification of iPSC-CM as 304 foetal like cardiomyocytes due to aspects of their electrophysiological and structural 305 phenotype, it could be that these cells express the non-insulin sensitive GLUT1 306 transporter in favour of GLUT4. 307
Therefore, quantification of GLUT1 and GLUT4 was performed in iPSC-CM and 308 the primary adult cardiomyocytes they are claimed to represent, by using 3T3-L1 309 adipocytes as a reference. Quantified expression of each transporter in this cell type 310 has been published previously, with an estimated 950,000 and 280,000 copies of Glut 311 1 and 4, respectively, per cell [32] . As shown in Fig. 4 and Table 1 , by comparing the 312 expression of GLUT4 normalised against GAPDH (loading control) in each source of 313 cardiomyocytes against the signals obtained from 3T3-L1 adipocytes, our data 314 suggest that iPSC-CM express approximately 8-fold less GLUT4 than primary adult 315 cardiomyocytes. In contrast, completion of identical analysis for GLUT1 (Fig. 5) 316 revealed iPSC-CM to express approximately 30-fold more of this transporter, relative 317 to primary cardiomyocytes. 318 319 Fig 4. GLUT4 protein expression in different cardiomyocyte models. Protein 320 lysates generated from 3T3-L1 adipocytes, primary adult mouse cardiomyocytes, and 321 iPSC-CM were subjected to SDS-PAGE and immunoblotting. Lysates were incubated 322 with antibodies probing for GLUT4 (1:2000, 1% milk, PBS-T) and GAPDH (1:80,000, 323 1% milk, PBS-T). Two different amounts of each sample of cardiomyocyte lysate from 324 three biologically independent sources were loaded, in addition to at least three 325 samples of 3T3-L1 adipocyte lysate. For each cell type, 1x refers to lysate generated Protein 332 lysates generated from 3T3-L1 adipocytes, primary adult mouse cardiomyocytes, and 333 iPSC-CM were subjected to SDS-PAGE and immunoblotting. Lysates were incubated 334 with antibodies probing for GLUT1 (1:1000, 1% milk, PBS-T) and GAPDH (1:80,000, 335 1% milk, PBS-T). Two different amounts of each sample of cardiomyocyte lysate from 336 three biologically independent sources were loaded, in addition to at least three 337 samples of 3T3-L1 adipocyte lysate. For each cell type, 1x refers to lysate generated 338 from approximately 15,000 (3T3-L1 adipocytes panel A), 17,500 (iPSC-CM), or 45,000 339 (3T3-L1 adipocytes panel B) 
